For the first time since the 340B contract pharmacy impasse started over a year and a half ago, the leader of an influential hospital group said publicly today her association is prepared to move in the direction of a federal legislative solution to the stalemate.
Speaking at the 340B Coalition annual winter conference in San Diego, 340B Health President and CEO Maureen Testoni said her group recognizes there will be “more decisions and ongoing lawsuits” over whether the 340B statute prohibits drug manufacturer restrictions on covered entities’ ability to dispense 340B-purchased drugs through contract pharmacies. Two federal district courts have agreed with the government that the statute prohibits such restrictions “and one has sided with the manufacturers,” she said.
For the first time since the 340B contract pharmacy impasse started over a year and half ago, the leader of an influential hospital group said publicly today her association is prepared to move in the direction of a federal legislative solution to the stalemate.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
